Top compounds associated with response to LRP5L


Feature Type Standardized
Nominal ANOVA
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA selumetinib:navitoclax (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA BX-912 GDSC1000 pan-cancer AAC 0.12 0.0002
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.11 0.0003
mRNA BRD-K02251932 CTRPv2 pan-cancer AAC 0.14 0.0004
mRNA BMS-708163 GDSC1000 pan-cancer AAC -0.13 0.0004
mRNA PX-12 CTRPv2 pan-cancer AAC 0.1 0.0004
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 0.0005
mRNA tacedinaline CTRPv2 pan-cancer AAC 0.14 0.0005
mRNA Doxorubicin CTRPv2 pan-cancer AAC 0.11 0.0005
Download CSV